Articles dans des revues avec comité de lecture (4)
  1. 1. Verstichel, G., Vermijlen, D., Martens, L., Goetgeluk, G., Brouwer, M., Thiault, N., van Caeneghem, Y., De Munter, S., Weening, K., Bonte, S., Leclercq, G., Taghon, T., Kerre, T., Saeys, Y., Van Dorpe, J., Cheroutre, H., & Vandekerckhove, B. (2017). The checkpoint for agonist selection precedes conventional selection in human thymus. Science immunology, 2, eaah4232. doi:10.1126/sciimmunol.aah4232
  2. 2. Dimova, T., Brouwer, M., Gosselin, F., Tassignon, J., Leo, O., donner, C., Marchant, A., & Vermijlen, D. (2015). Effector Vγ9Vδ2 T cells dominate the human fetal γδ T-cell repertoire. Proceedings of the National Academy of Sciences of the United States of America, 112(6), E556-E565. doi:10.1073/pnas.1412058112/-/DCSupplemental
  3. 3. Moens, E., Brouwer, M., Dimova, T., Goldman, M., Willems, F., & Vermijlen, D. (2011). IL-23R and TCR signaling drives the generation of neonatal Vgamma9Vdelta2 T cells expressing high levels of cytotoxic mediators and producing IFN-gamma and IL-17. Journal of leukocyte biology, 89(5), 743-752. doi:10.1189/jlb.0910501
  4. 4. Vermijlen, D., Brouwer, M., donner, C., Liesnard, C., Tackoen, M., Van Rysselberge, M., Twite, N., Goldman, M., Marchant, A., & Willems, F. (2010). Human cytomegalovirus elicits fetal gammadelta T cell responses in utero. The Journal of experimental medicine, 207(4), 807-821. doi:10.1084/jem.20090348